The Effect of Exercise Training on Quality of Life and Disease Progression in Fibrosing Interstitial Lung Patients

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

In this study, the progression of the disease and changes in quality of life will be examined over a 1-year follow-up period in groups of patients with Fibrosing Interstitial Lung Disease who either participated in or did not participate in a pulmonary rehabilitation program. After the initial evaluation, the patients will be randomized into two groups: one serving as the control group and the other as the pulmonary rehabilitation exercise group.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:

• Aged between 18-75 years

• Diagnosed with fibrosing interstitial lung disease according to the clinical diagnostic criteria of the American Thoracic Society and European Respiratory Society (ATS-ERS)

• Presence of dyspnea on exertion

• Stable clinical condition at the time of inclusion without infection or exacerbation in the previous 4 weeks

• Proficiency in using a smartphone

Locations
Other Locations
Turkey
Esra Pehli̇van
RECRUITING
Istanbul
Time Frame
Start Date: 2024-07-29
Estimated Completion Date: 2026-08-01
Participants
Target number of participants: 56
Treatments
Experimental: Exercise Group
In addition to standard medical treatment, the EGr will undergo an exercise program. The initial exercise training will be conducted in the hospital, followed by online exercise sessions via video conferencing three times a week during the first week. From the second week onwards, they will be asked to perform their exercises at home three times a week using provided exercise videos and will be monitored for one year. Compliance with the exercise regimen will be assessed through a weekly survey shared in a WhatsApp group established for the exercise group patients.
No_intervention: Control group
Patients in the CGr will receive an information brochure containing medical treatment and physical activity recommendations.
Sponsors
Leads: Istanbul Medipol University Hospital

This content was sourced from clinicaltrials.gov